16 December 2025
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
ADM TRONICS UNLIMITED, INC.
CIK: 849401•2 Annual Reports•Latest: 2025-07-14
10-K / July 14, 2025
Revenue:$3,197,110
Income:-$123,056
10-K / July 15, 2024
Revenue:$2,965,406
Income:-$877,222
10-K / July 14, 2025
Company Summary
Business Overview
- Type: Technology-based developer and manufacturer
- Founded: November 24, 1969
- Legal Structure: Corporation organized under Delaware laws
- Operations Conducted Through: ADM Tronics Unlimited, Inc. ("ADM") and its subsidiary Sonotron Medical Systems, Inc. ("SMI")
Core Activities
-
Electronics for Medical Devices and Other Applications:
- Develops and manufactures electronic technologies for non-invasive, electrotherapeutic, and diagnostic medical devices
- Serves veterinary and other applications
- Manufacturing occurs at FDA-Registered Medical Device Manufacturing facility in Northvale, NJ
- Produces both proprietary products and contract manufacturing for third-party companies
- As of March 31, 2025, backlog for electronic product orders was approximately $956,000
-
Environmentally Safe Chemical Products for Industrial Uses:
- Develops, manufactures, and sells water-based chemicals such as primers, adhesives, coatings, resins, chemical additives, and anti-static conductive paints
- Products used in industries like printing, food packaging, and manufacturing
- Emphasizes environmentally friendly, water-based systems as alternatives to solvent-based systems, claiming no known polluting effects or health hazards
- No patents protect these chemical formulations; some product names are trademarked
- Backlog for chemical products as of March 31, 2025, was not material
-
Medical and Cosmetic Products:
- Proprietary water-based, adhesive, and topical formulations for medical applications such as maxillofacial prosthetics
- Used for professional makeup and special effects in film, TV, and theater
-
Research, Development, Regulatory, and Engineering Services:
- Provides R&D, regulatory compliance, and engineering support for third parties in designing, developing, and manufacturing medical devices, electronics, and related technologies
- Services provided both on a fee-for-services and project basis
Customer Base
- During fiscal year ending March 31, 2025:
- 2 major customers accounted for 48% and 44% of net revenue
- Out of accounts receivable: 55% and 54% were from these customers
Market and Distribution
- Products are sold directly from Northvale, NJ, on FOB shipping basis
- Uses distributors who stock and ship products on their behalf
- Revenue depends heavily on a limited number of customers, making the company vulnerable if major customers are lost
Employees
- Number of Employees: Not specified in the provided text
Financials
- Revenue and Income:
- Exact revenue and income figures are not provided in this excerpt
- Focuses on backlog amounts, customer concentration, and operational factors rather than specific financial results
Other Key Details
- Facilities: Located at 224 Pegasus Avenue, Northvale, NJ
- Leased approximately 16,000 sq. ft. space, expiring June 2028
- Regulatory & Compliance:
- Manufacturing facility FDA-registered since 1988
- Complies with FDA quality standards and regulations
- Patents & Trademarks:
- No patents on chemical products; some trademarks for product names
- Research & Development Expenses:
- Fiscal years ending March 31, 2025 and 2024: $517,275 and $576,903 respectively
Summary
The company develops and manufactures electronics for medical and veterinary applications, produces environmentally friendly chemical products for industrial uses, and provides R&D and regulatory services for medical devices and electronics. It relies on a small number of major customers, maintains a single manufacturing facility, and faces typical industry regulatory and supply chain challenges.
